Senores Pharmaceuticals shareholding pattern
SENORES
816.75
0.90 (-0.11%)Last updated on 4 Feb, 2026 | 13:28 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Senores Pharmaceuticals reports the following shareholding: Total Promoters at 45.8%, Mutual Fund at 4.88%, Insurance at 2.66%, Foreign Institutional Investors at 3.35%, Domestic Institutional Investors at 1.77%, and Retail at 41.54%. This breakdown provides a quick snapshot of ownership distribution for Senores Pharmaceuticals in 2025-26.
Senores Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Senores Pharmaceuticals stands at 45.8% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Senores Pharmaceuticals is 3.35% and 1.77% respectively.
The retail shareholding of the Senores Pharmaceuticals is 41.54%.
Changes in shareholding patterns of Senores Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Senores Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
